Literature DB >> 10672496

The immunomodulatory role of CD4-positive cytotoxic T-lymphocytes in health and disease.

S Hahn1, P Erb.   

Abstract

Among the CD4-positive (CD4+) T-lymphocytes a population exists which expresses cytolytic activity. These 'killer' cells belong to the T helper type 1 (Th1) subset and if activated, express Fas-ligand (FasL) which induces apoptosis in Fas-positive target cells. The major targets of these CD4+ cytotoxic T-lymphocytes (CTL) are cells of the immune system, such as T, B cells and macrophages which express Fas upon activation. Thus, CD4+ CTL play a major immunoregulatory part through the elimination of activated myeloid and lymphoid cells during and upon completion of an immune response. In certain diseases, such as in HIV-infection and some autoimmune disorders, the functional activity of CD4+ CTL is disturbed preferentially at the level of FasL-Fas interaction, further emphasizing their important immunoregulatory role. Furthermore, Fas-ligand expressing tumors can evade the attack of Fas-positive CD4+ CTL and other effector cells, thereby giving them an opportunity to expand.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10672496     DOI: 10.3109/08830189909088493

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  8 in total

1.  Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).

Authors:  N Porakishvili; T Roschupkina; T Kalber; A P Jewell; K Patterson; K Yong; P M Lydyard
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

2.  Cytotoxic HIV-1 p55gag-specific CD4+ T cells produce HIV-inhibitory cytokines and chemokines.

Authors:  Barbara Lotti; Thomas Wendland; Hansjakob Furrer; Nikhil Yawalkar; Salome von Greyerz; Karin Schnyder; Marlène Brandes; Pietro Vernazza; Ralf Wagner; Thi Nguyen; Eric Rosenberg; Werner J Pichler; Christian Brander
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

3.  Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques.

Authors:  Alexandra M Ortiz; Nichole R Klatt; Bing Li; Yanjie Yi; Brian Tabb; Xing Pei Hao; Lawrence Sternberg; Benton Lawson; Paul M Carnathan; Elizabeth M Cramer; Jessica C Engram; Dawn M Little; Elena Ryzhova; Francisco Gonzalez-Scarano; Mirko Paiardini; Aftab A Ansari; Sarah Ratcliffe; James G Else; Jason M Brenchley; Ronald G Collman; Jacob D Estes; Cynthia A Derdeyn; Guido Silvestri
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 4.  Disturbances in placental immunology: ready for therapeutic interventions?

Authors:  Sinuhe Hahn; Anurag Kumar Gupta; Carolyn Troeger; Corinne Rusterholz; Wolfgang Holzgreve
Journal:  Springer Semin Immunopathol       Date:  2006-04-26

5.  Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51.

Authors:  Y He; R Vemulapalli; A Zeytun; G G Schurig
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.

Authors:  Silvia Melgar; Anna Bas; Sten Hammarström; Marie-Louise Hammarström
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

7.  Matrix Metalloproteinases Retain Soluble FasL-mediated Resistance to Cell Death in Fibrotic-Lung Myofibroblasts.

Authors:  David Nareznoi; Jenya Konikov-Rozenman; Dmytro Petukhov; Raphael Breuer; Shulamit B Wallach-Dayan
Journal:  Cells       Date:  2020-02-11       Impact factor: 6.600

8.  Therapeutic effects of bee venom and its major component, melittin, on atopic dermatitis in vivo and in vitro.

Authors:  Hyun-Jin An; Jung-Yeon Kim; Woon-Hae Kim; Mi-Gyeong Gwon; Hye Min Gu; Min Ji Jeon; Sang-Mi Han; Sok Cheon Pak; Chong-Kee Lee; In Sook Park; Kwan-Kyu Park
Journal:  Br J Pharmacol       Date:  2018-11-06       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.